An extensive series of studies by Kappas and Drummond (see review in reference 1) has demonstrated that the synthetic heme analogue, tin(Sn)-protoporphyrin (SnPP) acts as a potent competitive inhibitor of heme oxygenase (2) (3) (4) , and can suppress hyperbilirubinemia in experimentally induced and naturally occurring forms ofjaundice in animals and man (2, 3, 5, 6) . SnPP also significantly diminishes the output of biliary bilirubin derived from endogenous and exogenous heme sources (7), does not affect the metabolic disposition of preformed bilirubin (7) , and elicits a marked biliary excretion of untransformed heme in bile duct-cannulated animals (8) .
In the process of heme degradation catalyzed by the enzyme heme oxygenase, one mole of carbon dioxide (CO) is generated for each mole of bile pigment produced (9, 10) . Thus the findings reported above would support the expectation that SnPP would diminish the generation of CO from the catabolism of various heme moieties in vivo . We have examined this question by studying the generation of "CO from radiolabeled heme sources in the intact animal . The use of specifically labeled heme is crucial in answering this question since CO may be generated from sources other than heme (11) (12) (13) (14) . The results of these experiments prove conclusively that SnPP markedly inhibits the enzymatic oxidation in vivo of heme from both endogenous and exogenous sources.
Materials and Methods
Animals used were 300-400 g Sprague-Dawley rats obtained from Taconic Farms, Germantown, NY. SnPP was provided by Porphyrin Products, Logan, UT. The labeled precursor 6-aminolevulinic acid (5-['4C]ALA) (Sp act, 49 mCi/mM) was obtained from New England Nuclear, Boston, MA. Labeled ["C]hemin (Sp act, 3.0 X 10' dpm/mg) was prepared in rats by methods previously described (9) . Before injection into animals, 1 .0 mg of the crystallized hemin was dissolved in 1 ml of alkalinized rat plasma, and injected intravenously within 15 min of preparation. SnPP was dissolved in a small amount of 0.2 N NaOH, a 3.5-fold greater volume of 0.9% NaCl was added, and pH was adjusted to Semilogarithmic plot of the excretion rate of "CO (dpm/h, ordinate) vs . time after injection of 5-["C]ALA (h, abscissa) . To facilitate comparisons within this figure and with the results shown in Fig . 2 , all "CO excretion data for control (salineinjected) animals were normalized such that total 14CO excretion in the period 0-12 h after ALA injection was set at 100,000 dpm. For experimental animals, data were normalized for a dose-of ALA that yielded 100,000 dpm in the first 12 h for the control animal run on the same date. The shaded area denotes the total range of normalized values for four control animals injected with saline 1 h before 5-["C]ALA . Results from four animals injected with SnPP (50 ,umol/kg body weight) 1 h before injection of 5-["C]ALA are shown (often circles, mean ± SD) . Note that the inhibition of "CO excretion produced by SnPP was rapid, and the effect appeared to last^-8-9 h. 7 .5 by dropwise addition of 0.5 N HCI (6) . The compound was injected subcutaneously in a dose of 50 lamol/kg body weight at various time periods before or after injection of the labeled materials . Equal volumes of saline were injected by the same route for the control animals .
The degradation of labeled heme was followed by quantitation of the excretion of "Clabeled carbon monoxide ("CO), using previously described methods (9) . Immediately after injection of labeled material, rats were placed in flow-through metabolic chambers provided with food, water, and bedding. Labeled "CO was then collected continuously over the next 24-30 h, and expressed as dpm of "CO excreted over various time intervals . Student's t test was used to determine the statistical significance of results .
Results
Effect of SnPP on "CO Generation after 5-[ 14 C]ALA Administration . In the rat, 5-[ 14 C]ALA is incorporated almost exclusively into nonerythropoietic hernes (15, 16) , labeling bilirubin and CO to very high activity within minutes of injection (17, 18) . The peak of "CO excretion occurs early, about 2-3 h after injection of 5-[ 14 C]ALA, and is followed by a rapid exponential decline (Fig . 1) , with 3-4% of the injected dose appearing as "CO within the first 12 h after injection (Table 1) .
When 50 Amol/kg body weight of SnPP was injected 1 h before injection of 5-[ 14 C]ALA, there was a prompt reduction in "CO excretion, lasting^-8-9 h (Fig . 1) . The peak of "CO excretion at 2-3 h was virtually abolished, and total 14 C0 excretion in the first 12 h was reduced by^-60% (p < 0.005, Table I ) . Thereafter, "CO excretion was identical to the control animals (Table I and Fig . 1) .
In separate experiments, SnPP or saline was injected subcutaneously into four rats 11 h after 5-[ 14 C]ALA; "CO excretion was monitored for the entire time period 0-35 h after 5-[ 14 C]ALA injection . When compared with controls, 14 CO excretion was reduced 48% for the time period for 12-24 h after injection of 5-[ 14C]ALA corresponding to 1-13 h after injection of SnPP (Fig . 2) . 14 CO excretion rates were similar to controls before injection of SnPP (0-10 h after (9) was injected intravenously in alkalinized plasma to eight rats, divided into four pairs . From each pair, one rat was injected with SnPP and the other with saline, to control for day-to-day variability in the preparation of solubilized hemin. As with 5-[ 14 C]ALA, excretion of labeled bilirubin and CO after [ 14C]hemin is rapid (9), with peak excretion occurring 2-3 h after injection, 5-22% of the injected dose appearing as 14CO within 12 h after injection (Table I) .
When 50 Amol/kg body weight SnPP was injected 1 h before [ 14 C]hemin, there was a 46% reduction (p < 0.01, consistent reduction in "CO excretion in SnPP-treated animals (mean decline, 34%), but this value did not reach statistical significance (p > 0.05, Table 1 ).
Discussion
Drummond and Kappas proposed that (2) the mechanism of suppression of hyperbilirubinemia by SnPP involves a potent and sustained competitive inhibition of heme oxygenase by this synthetic metalloporphyrin . Such a mechanism would presuppose a concurrent diminution of production of bilirubin as well as of CO after treatment of animals with this synthetic heme analogue. Suppression of bilirubin production by SnPP has been confirmed (7) . Milleville et al . (19, 20) and more recently Posselt et al. (21) , using mature mouse and newborn rat models, respectively, but without using radiolabeled heme, have reported that SnPP reduces CO generation from endogenous heme and from heme derived from hematomas as well as exogenous sources, by^-18-30% and 35-56%, respectively . The variable time periods between injection of SnPP and its effects on CO production probably account for the differences in effects noted in these experiments .
The results of the present study, using highly specific techniques for quantitating "CO generation from the catabolism of radiolabeled heme moieties, conclusively establish that SnPP suppresses CO generation and does so at rates comparable to those by which biliary bile pigment output is diminished by SnPP (7) . The experiments described here indicate that, when 5-["C]ALA is used as a heme precursor, the suppressive effect of SnPP on "CO excretion lasts about 8-20 h, whether the metalloporphyrin is given 1 h before (Fig. 1 ) or 11 h after (Fig. 2 ) the 5-[`4C]ALA. These observations thus suggest a duration of action in vivo of a single dose of SnPP in the range of about 12 h, despite the prolonged retention (in part in nonenzymatic tissue sites as previously suggested [22] ) of the compound in the liver and other organs . Our findings also suggest that degradation of the heme moieties of both rapid and relatively slowly turning over hemeproteins in the liver is suppressed by SnPP. Kappas et al. (8) have reported that the administration of SnPP leads to a marked increase in the biliary excretion of untransformed heme after the injection of both hemin and heat-damaged red blood cells, and that this excretion of heme quantitatively accounts for much of the concurrent decline seen in the output of biliary bilirubin . Similar results have recently been reported by Hintz et al. (23) . The effect of SnPP on heme excretion after the administration of heat-damaged red blood cells, though significant, was less than that seen after injection of hemin, and was more variable in individual animals (7) . This suggests that SnPP can inhibit to some extent extrahepatic heme degradation in vivo, as well as hepatic heme catabolism. The in vivo effects of SnPP in the liver and in extrahepatic tissues such as the spleen, however, are probably not equal, since the findings of Simionatto et al. (7), using heat-damaged erythrocytes, could be explained in part by the transport of unmetabolized, excess heme or hemoglobin from splenic to hepatic sites for degradation . Thus, significant inhibition of heme catabolism by SnPP may be primarily manifest on liver heme moieties or in circumstances when the organism is presented with a substantial excess of heme, excretion by -50% . These findings, derived from experiments using radiolabeled endogenous and exogenous heme sources, establish conclusively that the synthetic metalloporphyrin SnPP inhibits the oxidative degradation of heme in the intact animal .
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